litlas
ログインアカウント作成

David Raben

1978–2025 年に発表

65
論文数
19,162
被引用数
55
h 指数
63
i10 指数

被引用数

David Raben の年別被引用数1980 年: 被引用 4 件1981 年: 被引用 2 件1983 年: 被引用 1 件1985 年: 被引用 2 件1987 年: 被引用 1 件1994 年: 被引用 4 件1995 年: 被引用 5 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 13 件2000 年: 被引用 16 件2001 年: 被引用 13 件2002 年: 被引用 18 件2003 年: 被引用 26 件2004 年: 被引用 33 件2005 年: 被引用 47 件2006 年: 被引用 63 件2007 年: 被引用 103 件2008 年: 被引用 114 件2009 年: 被引用 110 件2010 年: 被引用 160 件2011 年: 被引用 127 件2012 年: 被引用 125 件2013 年: 被引用 129 件2014 年: 被引用 145 件2015 年: 被引用 134 件2016 年: 被引用 147 件2017 年: 被引用 158 件2018 年: 被引用 115 件2019 年: 被引用 697 件2020 年: 被引用 641 件2021 年: 被引用 585 件2022 年: 被引用 439 件2023 年: 被引用 346 件2024 年: 被引用 479 件2025 年: 被引用 218 件2026 年: 被引用 8 件1982 年は被引用が無いため表示していません1984 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1988〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,096 件、この内訳の 29.2%中国: 引用元論文 831 件、この内訳の 11.6%ドイツ: 引用元論文 371 件、この内訳の 5.2%イギリス: 引用元論文 346 件、この内訳の 4.8%イタリア: 引用元論文 312 件、この内訳の 4.3%フランス: 引用元論文 305 件、この内訳の 4.2%カナダ: 引用元論文 258 件、この内訳の 3.6%オランダ: 引用元論文 239 件、この内訳の 3.3%日本: 引用元論文 218 件、この内訳の 3%スペイン: 引用元論文 177 件、この内訳の 2.5%オーストラリア: 引用元論文 158 件、この内訳の 2.2%韓国: 引用元論文 137 件、この内訳の 1.9%
0%29.2%その他 24.2%

機関

分野

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology22.3%
  • Immunology and Microbiology4.3%
  • Engineering1.2%
  • Physics and Astronomy0.9%
  • Neuroscience0.7%
  • その他3.1%

トピック

  • Head and Neck Cancer Studies9.9%
  • Cancer Immunotherapy and Biomarkers4.4%
  • Lung Cancer Treatments and Mutations3.8%
  • Esophageal Cancer Research and Treatment2.3%
  • Head and Neck Surgical Oncology2%
  • HER2/EGFR in Cancer Research1.9%
  • その他75.7%

共著者

全論文

検索で開く
  1. Head and neck cancer

    著者: Athanassios Argiris, Michalis V. Karamouzis, David Raben, Robert L. Ferris - The Lancet 2008 被引用: 2,220

  2. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    著者: James A. Bonner, Paul M. Harari, J. Giralt, N. Azarnia, Dong M. Shin, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Merrill S. Kies, José Baselga, Hagop Youssoufian, Nadia Amellal, Eric K. Rowinsky, K. Kian Ang - New England Journal of Medicine 2006 被引用: 5,106

  3. Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy

    著者: Qian Huang, Fang Li, Xinjian Liu, Wenrong Li, Wei Shi, Fei‐Fei Liu, Brian O’Sullivan, Zhimin He, Yuanlin Peng, Aik Choon Tan, Ling Zhou, Jingping Shen, Gangwen Han, Xiao‐Jing Wang, Jackie Thorburn, Andrew Thorburn, Antonio Jimeno, David Raben, Joel S. Bedford, Chuan‐Yuan Li - Nature Medicine 2011 被引用: 896

  4. A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

    著者: Laurel B. Darragh, Michael W. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit, Von Samedi, Andrew N. Bubak, Casey S. Greene, Timothy V. Waxweiler, Sanjana Mehrotra, Shilpa Bhatia, Jacob Gadwa, Thomas E. Bickett, Miles Piper, Kareem Fakhoury, Arthur Liu, Joshua H. Petit, Daniel W. Bowles, Ashesh A. Thaker, Kimberly Atiyeh, Julie Goddard, Robert Hoyer, Adrie van Bokhoven, Kimberly R. Jordan, Antonio Jimeno, Angelo D’Alessandro, David Raben, Jessica D. McDermott, Sana D. Karam - Nature Cancer 2022 被引用: 91

  5. Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration

    著者: Ayman Oweida, Mohammad K. Hararah, Andy V. Phan, David C. Binder, Shilpa Bhatia, Shelby Lennon, Sanjana Bukkapatnam, Benjamin Van Court, Nomin Uyanga, Laurel B. Darragh, H. Mike Kim, David Raben, Aik Choon Tan, Lynn E. Heasley, Eric T. Clambey, Raphael A. Nemenoff, Sana D. Karam - Clinical Cancer Research 2018 被引用: 279

  6. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

    著者: James A. Bonner, Paul M. Harari, J. Giralt, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, José Baselga, Sharon A. Spencer, Junming Zhu, Hagop Youssoufian, Eric K. Rowinsky, K. Kian Ang - The Lancet Oncology 2009 被引用: 1,974

  7. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

    著者: Brian O’Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis, Kristina R. Dahlstrom, Nancy Y. Lee, Nadeem Riaz, Xin Pei, Shlomo A. Koyfman, David J. Adelstein, Brian B. Burkey, Jeppe Friborg, Claus Andrup Kristensen, Anita Gothelf, Frank Hoebers, Bernd Kremer, Ernst‐Jan M. Speel, Daniel W. Bowles, David Raben, Sana D. Karam, Eugene Yu, Wei Xu - The Lancet Oncology 2016 被引用: 741

  8. Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

    著者: Luis Paz‐Ares, Alexander I. Spira, David Raben, David Planchard, Byoung Chul Cho, Mustafa Özgüroğlu, Davey B. Daniel, Augusto Villegas, David Vicente, Rina Hui, S. Murakami, David R. Spigel, Suresh Senan, Corey J. Langer, Bradford A. Perez, A-M. Boothman, Helen Broadhurst, Catherine Wadsworth, P. Dennis, Scott Antonia, Corinne Faivre‐Finn - Annals of Oncology 2020 被引用: 224

  9. Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

    著者: Diana Merino Vega, Katherine K. Nishimura, Névine Zariffa, Jeffrey C. Thompson, Antje Hoering, Vanessa Cilento, Adam Rosenthal, Valsamo Anagnostou, Jonathan Baden, Julia A. Beaver, Aadel A. Chaudhuri, Darya Chudova, Alexander D. Fine, Joseph Fiore, Rachel Hodge, Darren Hodgson, Nathan Hunkapiller, Daniel M. Klass, Julie Kobie, Carol E. Peña, Gene Pennello, Neil Peterman, Reena Philip, Katie Quinn, David Raben, Gary L. Rosner, Mark Sausen, Ayse Tezcan, Qi Xia, Jing Yi, Amanda Young, Mark Stewart, Erica L. Carpenter, Charu Aggarwal, Jeff Allen - JCO Precision Oncology 2022 被引用: 75

  10. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer

    著者: Ayman Oweida, Laurel B. Darragh, Andy V. Phan, David C. Binder, Shilpa Bhatia, Adam C. Mueller, Benjamin Van Court, Dallin Milner, David Raben, Richard Woessner, Lynn E. Heasley, Raphael A. Nemenoff, Eric T. Clambey, Sana D. Karam - JNCI Journal of the National Cancer Institute 2019 被引用: 153

  11. Prostate Cancer, Version 1.2016

    著者: James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony V. D’Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, David Raben, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2016 被引用: 655

  12. The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer

    著者: Eric C. Ko, David Raben, Silvia C. Formenti - Clinical Cancer Research 2018 被引用: 300

  13. Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma

    著者: Ayman Oweida, Shelby Lennon, Dylan Calame, Sean P. Korpela, Shilpa Bhatia, Jaspreet Sharma, Caleb Graham, David C. Binder, Natalie J. Serkova, David Raben, Lynn E. Heasley, Eric T. Clambey, Raphael A. Nemenoff, Sana D. Karam - OncoImmunology 2017 被引用: 126

  14. p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma

    著者: Christine H. Chung, Qiang Zhang, Christina S. Kong, Jonathan Harris, Elana J. Fertig, Paul M. Harari, Dian Wang, Kevin P. Redmond, George Shenouda, Andy Trotti, David Raben, Maura L. Gillison, Richard C. Jordan, Quynh‐Thu Le - Journal of Clinical Oncology 2014 被引用: 377

  15. Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

    著者: Sana D. Karam, Krishna Reddy, Patrick J. Blatchford, Tim Waxweiler, Alicia M. DeLouize, Ayman Oweida, Hilary Somerset, Carrie B. Marshall, Christian D. Young, Kurtis D. Davies, Madeleine Kane, Aik Choon Tan, Xiaojing Wang, Antonio Jimeno, Dara L. Aisner, Daniel W. Bowles, David Raben - Clinical Cancer Research 2018 被引用: 93

  16. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

    著者: Solange Peters, Urania Dafni, Michael Boyer, Dirk De Ruysscher, Corinne Faivre‐Finn, Enriqueta Felip, Pilar Garrido, Nicolas Girard, Matthias Gückenberger, John B.A.G. Haanen, C. Le Péchoux, F. Mornex, Mahmut Özsahin, Luis Paz‐Ares, David Planchard, David Raben, Suresh S. Ramalingam, Martin Reck, Egbert F. Smit, R. Stahel, Albrecht Stenzinger, Charles Swanton, S. Vallone, Marina Chiara Garassino - Annals of Oncology 2019 被引用: 76

  17. Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC)

    著者: David Raben, Andreas Rimner, Suresh Senan, Helen Broadhurst, Theodore C. Pellas, Phillip A. Dennis, Corinne Faivre‐Finn - International Journal of Radiation Oncology*Biology*Physics 2019 被引用: 66

  18. Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

    著者: Vasu Divi, Jonathan Harris, Paul M. Harari, Jay S. Cooper, Jonathan B. McHugh, Diana Bell, Erich M. Sturgis, Anthony J. Cmelak, Mohan Suntharalingam, David Raben, Harold Kim, Sharon A. Spencer, George E. Laramore, Andy Trotti, Robert L. Foote, Christopher J. Schultz, Wade L. Thorstad, Qiang Zhang, Quynh‐Thu Le, F. Christopher Holsinger - Cancer 2016 被引用: 104

  19. A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

    著者: Thomas J. Galloway, Lori J. Wirth, A. D. Colevas, Jill Gilbert, Julie E. Bauman, Nabil F. Saba, David Raben, Ranee Mehra, Anna Walaszczyk, Ruzanna Atoyan, Jing Wang, Barbara Burtness, Antonio Jimeno - Clinical Cancer Research 2015 被引用: 99

  20. A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins

    著者: Stephen B. Keysar, David P. Astling, Ryan T. Anderson, Brian W. Vogler, Daniel W. Bowles, J. Jason Morton, Jeramiah J. Paylor, Magdalena J. Glogowska, Phuong N. Le, Justin R. Eagles-Soukup, Severine Kako, Sarah M. Takimoto, Daniel Sehrt, Adrian Umpierrez, Morgan A. Pittman, Sarah M. Macfadden, Ryan M. Helber, Scott Peterson, Diana F. Hausman, Sherif Said, Ted H. Leem, Julie Goddard, John J. Arcaroli, Wells A. Messersmith, William A. Robinson, Fred R. Hirsch, Marileila Varella‐Garcia, David Raben, Xiao‐Jing Wang, John I. Song, Aik Choon Tan, Antonio Jimeno - Molecular Oncology 2013 被引用: 164

  21. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma

    著者: Arya Amini, Timothy V. Waxweiler, Jeffrey V. Brower, Bernard L. Jones, Jessica D. McDermott, David Raben, Debashis Ghosh, Daniel W. Bowles, Sana D. Karam - JAMA Otolaryngology–Head & Neck Surgery 2016 被引用: 132

  22. Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies

    著者: Reshmi S. Nair, Veena Somasundaram, Anshu Kuriakose, Shiv Ram Krishn, David Raben, Rachel Salazar, Pradip Nair - Frontiers in Immunology 2025 被引用: 58

  23. Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma

    著者: Alexander A. Strait, Rachel A. Woolaver, Spencer C. Hall, Christian D. Young, Sana D. Karam, Antonio Jimeno, Yan Lan, David Raben, Jing Wang, Xiao‐Jing Wang - Communications Biology 2021 被引用: 21

  24. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies

    著者: Tyler P. Robin, Bernard L. Jones, Oren Gordon, Andy V. Phan, Diana Abbott, Jessica D. McDermott, Julie Goddard, David Raben, Ryan M. Lanning, Sana D. Karam - Cancer 2017 被引用: 172